A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy

Detalhes bibliográficos
Autor(a) principal: Ludwig,Natasha G.
Data de Publicação: 2016
Outros Autores: Radaeli,Rafael F., Silva,Mariana M. X., Romero,Camila M., Carrilho,Alexandre J. F., Bessa,Danielle, Macedo,Delanie B., Oliveira,Maria L., Latronico,Ana Claudia, Mazzuco,Tânia L.
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Arquivos de Endocrinologia e Metabolismo (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000600596
Resumo: SUMMARY Prader-Willi syndrome (PWS) is a genetic disorder frequently characterized by obesity, growth hormone deficiency, genital abnormalities, and hypogonadotropic hypogonadism. Incomplete or delayed pubertal development as well as premature adrenarche are usually found in PWS, whereas central precocious puberty (CPP) is very rare. This study aimed to report the clinical and biochemical follow-up of a PWS boy with CPP and to discuss the management of pubertal growth. By the age of 6, he had obesity, short stature, and many clinical criteria of PWS diagnosis, which was confirmed by DNA methylation test. Therapy with recombinant human growth hormone (rhGH) replacement (0.15 IU/kg/day) was started. Later, he presented psychomotor agitation, aggressive behavior, and increased testicular volume. Laboratory analyses were consistent with the diagnosis of CPP (gonadorelin-stimulated LH peak 15.8 IU/L, testosterone 54.7 ng/dL). The patient was then treated with gonadotropin-releasing hormone analog (GnRHa). Hypothalamic dysfunctions have been implicated in hormonal disturbances related to pubertal development, but no morphologic abnormalities were detected in the present case. Additional methylation analysis (MS-MLPA) of the chromosome 15q11 locus confirmed PWS diagnosis. We presented the fifth case of CPP in a genetically-confirmed PWS male. Combined therapy with GnRHa and rhGH may be beneficial in this rare condition of precocious pubertal development in PWS.
id SBEM-1_61ae59037c35c9159c58b4295efbf8c3
oai_identifier_str oai:scielo:S2359-39972016000600596
network_acronym_str SBEM-1
network_name_str Arquivos de Endocrinologia e Metabolismo (Online)
repository_id_str
spelling A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapySUMMARY Prader-Willi syndrome (PWS) is a genetic disorder frequently characterized by obesity, growth hormone deficiency, genital abnormalities, and hypogonadotropic hypogonadism. Incomplete or delayed pubertal development as well as premature adrenarche are usually found in PWS, whereas central precocious puberty (CPP) is very rare. This study aimed to report the clinical and biochemical follow-up of a PWS boy with CPP and to discuss the management of pubertal growth. By the age of 6, he had obesity, short stature, and many clinical criteria of PWS diagnosis, which was confirmed by DNA methylation test. Therapy with recombinant human growth hormone (rhGH) replacement (0.15 IU/kg/day) was started. Later, he presented psychomotor agitation, aggressive behavior, and increased testicular volume. Laboratory analyses were consistent with the diagnosis of CPP (gonadorelin-stimulated LH peak 15.8 IU/L, testosterone 54.7 ng/dL). The patient was then treated with gonadotropin-releasing hormone analog (GnRHa). Hypothalamic dysfunctions have been implicated in hormonal disturbances related to pubertal development, but no morphologic abnormalities were detected in the present case. Additional methylation analysis (MS-MLPA) of the chromosome 15q11 locus confirmed PWS diagnosis. We presented the fifth case of CPP in a genetically-confirmed PWS male. Combined therapy with GnRHa and rhGH may be beneficial in this rare condition of precocious pubertal development in PWS.Sociedade Brasileira de Endocrinologia e Metabologia2016-12-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000600596Archives of Endocrinology and Metabolism v.60 n.6 2016reponame:Arquivos de Endocrinologia e Metabolismo (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.1590/2359-3997000000196info:eu-repo/semantics/openAccessLudwig,Natasha G.Radaeli,Rafael F.Silva,Mariana M. X.Romero,Camila M.Carrilho,Alexandre J. F.Bessa,DanielleMacedo,Delanie B.Oliveira,Maria L.Latronico,Ana ClaudiaMazzuco,Tânia L.eng2016-12-08T00:00:00Zoai:scielo:S2359-39972016000600596Revistahttps://www.aem-sbem.com/https://old.scielo.br/oai/scielo-oai.php||aem.editorial.office@endocrino.org.br2359-42922359-3997opendoar:2016-12-08T00:00Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false
dc.title.none.fl_str_mv A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
title A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
spellingShingle A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
Ludwig,Natasha G.
title_short A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
title_full A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
title_fullStr A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
title_full_unstemmed A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
title_sort A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy
author Ludwig,Natasha G.
author_facet Ludwig,Natasha G.
Radaeli,Rafael F.
Silva,Mariana M. X.
Romero,Camila M.
Carrilho,Alexandre J. F.
Bessa,Danielle
Macedo,Delanie B.
Oliveira,Maria L.
Latronico,Ana Claudia
Mazzuco,Tânia L.
author_role author
author2 Radaeli,Rafael F.
Silva,Mariana M. X.
Romero,Camila M.
Carrilho,Alexandre J. F.
Bessa,Danielle
Macedo,Delanie B.
Oliveira,Maria L.
Latronico,Ana Claudia
Mazzuco,Tânia L.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ludwig,Natasha G.
Radaeli,Rafael F.
Silva,Mariana M. X.
Romero,Camila M.
Carrilho,Alexandre J. F.
Bessa,Danielle
Macedo,Delanie B.
Oliveira,Maria L.
Latronico,Ana Claudia
Mazzuco,Tânia L.
description SUMMARY Prader-Willi syndrome (PWS) is a genetic disorder frequently characterized by obesity, growth hormone deficiency, genital abnormalities, and hypogonadotropic hypogonadism. Incomplete or delayed pubertal development as well as premature adrenarche are usually found in PWS, whereas central precocious puberty (CPP) is very rare. This study aimed to report the clinical and biochemical follow-up of a PWS boy with CPP and to discuss the management of pubertal growth. By the age of 6, he had obesity, short stature, and many clinical criteria of PWS diagnosis, which was confirmed by DNA methylation test. Therapy with recombinant human growth hormone (rhGH) replacement (0.15 IU/kg/day) was started. Later, he presented psychomotor agitation, aggressive behavior, and increased testicular volume. Laboratory analyses were consistent with the diagnosis of CPP (gonadorelin-stimulated LH peak 15.8 IU/L, testosterone 54.7 ng/dL). The patient was then treated with gonadotropin-releasing hormone analog (GnRHa). Hypothalamic dysfunctions have been implicated in hormonal disturbances related to pubertal development, but no morphologic abnormalities were detected in the present case. Additional methylation analysis (MS-MLPA) of the chromosome 15q11 locus confirmed PWS diagnosis. We presented the fifth case of CPP in a genetically-confirmed PWS male. Combined therapy with GnRHa and rhGH may be beneficial in this rare condition of precocious pubertal development in PWS.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000600596
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000600596
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/2359-3997000000196
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
dc.source.none.fl_str_mv Archives of Endocrinology and Metabolism v.60 n.6 2016
reponame:Arquivos de Endocrinologia e Metabolismo (Online)
instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
instname_str Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron_str SBEM
institution SBEM
reponame_str Arquivos de Endocrinologia e Metabolismo (Online)
collection Arquivos de Endocrinologia e Metabolismo (Online)
repository.name.fl_str_mv Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
repository.mail.fl_str_mv ||aem.editorial.office@endocrino.org.br
_version_ 1752122514377539584